• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于与1型强直性肌营养不良相关的RNA重复转录本协同结合的“微型”核酸探针的设计

Design of a "Mini" Nucleic Acid Probe for Cooperative Binding of an RNA-Repeated Transcript Associated with Myotonic Dystrophy Type 1.

作者信息

Hsieh Wei-Che, Bahal Raman, Thadke Shivaji A, Bhatt Kirti, Sobczak Krzysztof, Thornton Charles, Ly Danith H

机构信息

Department of Chemistry, ‡Institute for Biomolecular Design and Discovery (IBD), and §CNAST, Carnegie Mellon University , 4400 Fifth Avenue, Pittsburgh, Pennsylvania 15213, United States.

Department of Neurology, Box 645, University of Rochester Medical Center , 601 Elmwood Avenue, Rochester, New York 14642, United States.

出版信息

Biochemistry. 2018 Feb 13;57(6):907-911. doi: 10.1021/acs.biochem.7b01239. Epub 2018 Jan 19.

DOI:10.1021/acs.biochem.7b01239
PMID:29334465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6091549/
Abstract

Toxic RNAs containing expanded trinucleotide repeats are the cause of many neuromuscular disorders, one being myotonic dystrophy type 1 (DM1). DM1 is triggered by CTG-repeat expansion in the 3'-untranslated region of the DMPK gene, resulting in a toxic gain of RNA function through sequestration of MBNL1 protein, among others. Herein, we report the development of a relatively short miniPEG-γ peptide nucleic acid probe, two triplet repeats in length, containing terminal pyrene moieties, that is capable of binding rCUG repeats in a sequence-specific and selective manner. The newly designed probe can discriminate the pathogenic rCUG from the wild-type transcript and disrupt the rCUG-MBNL1 complex. The work provides a proof of concept for the development of relatively short nucleic acid probes for targeting RNA-repeat expansions associated with DM1 and other related neuromuscular disorders.

摘要

含有扩展三核苷酸重复序列的毒性RNA是许多神经肌肉疾病的病因,其中之一是1型强直性肌营养不良症(DM1)。DM1由DMPK基因3'-非翻译区的CTG重复序列扩增引发,导致RNA功能毒性增加,其中包括通过隔离MBNL1蛋白。在此,我们报告了一种相对较短的miniPEG-γ肽核酸探针的研发,其长度为两个三联体重复序列,含有末端芘基团,能够以序列特异性和选择性方式结合rCUG重复序列。新设计的探针可以区分致病性rCUG与野生型转录本,并破坏rCUG-MBNL1复合物。这项工作为开发针对与DM1及其他相关神经肌肉疾病相关的RNA重复序列扩增的相对较短核酸探针提供了概念验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/31af1427ad95/nihms983791f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/9e79308eeb78/nihms983791f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/f42edb05c784/nihms983791f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/5c1904344f05/nihms983791f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/cccc5a18c447/nihms983791f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/e61f9253a1bb/nihms983791f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/31af1427ad95/nihms983791f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/9e79308eeb78/nihms983791f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/f42edb05c784/nihms983791f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/5c1904344f05/nihms983791f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/cccc5a18c447/nihms983791f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/e61f9253a1bb/nihms983791f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0472/6091549/31af1427ad95/nihms983791f6.jpg

相似文献

1
Design of a "Mini" Nucleic Acid Probe for Cooperative Binding of an RNA-Repeated Transcript Associated with Myotonic Dystrophy Type 1.用于与1型强直性肌营养不良相关的RNA重复转录本协同结合的“微型”核酸探针的设计
Biochemistry. 2018 Feb 13;57(6):907-911. doi: 10.1021/acs.biochem.7b01239. Epub 2018 Jan 19.
2
Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain.肌强直性营养不良大脑中 MBNL1 介导的逆行 BDNF 信号转导丧失。
Acta Neuropathol Commun. 2023 Mar 15;11(1):44. doi: 10.1186/s40478-023-01540-x.
3
Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.强直性肌营养不良患者的富克斯角膜内皮营养不良与RNA病灶
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4579-4585. doi: 10.1167/iovs.17-22350.
4
Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.系统递送肽连接的吗啉代寡核苷酸可中和肌强直性营养不良小鼠模型中的突变 RNA 毒性。
Nucleic Acid Ther. 2013 Apr;23(2):109-17. doi: 10.1089/nat.2012.0404. Epub 2013 Jan 11.
5
A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.基于流式细胞术的筛选鉴定出可挽救I型强直性肌营养不良症剪接缺陷的MBNL1调节剂。
Hum Mol Genet. 2017 Aug 15;26(16):3056-3068. doi: 10.1093/hmg/ddx190.
6
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.短反义锁核酸(全锁核酸)可纠正强直性肌营养不良中的异常剪接。
Nucleic Acids Res. 2015 Mar 31;43(6):3318-31. doi: 10.1093/nar/gkv163. Epub 2015 Mar 9.
7
Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.针对导致RNA显性疾病的三联体重复转录本的配体的合理设计:应用于1型强直性肌营养不良和3型脊髓小脑共济失调。
J Am Chem Soc. 2009 Jul 22;131(28):9767-79. doi: 10.1021/ja9020149.
8
Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy.定量监测肌强直性营养不良 RNA 生物标志物的方法。
Sci Rep. 2018 Apr 12;8(1):5885. doi: 10.1038/s41598-018-24156-x.
9
Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.心脏elav型RNA结合蛋白(ETR-3)与强直性肌营养不良中扩增的RNA CUG重复序列结合。
Hum Mol Genet. 1999 Jan;8(1):53-60. doi: 10.1093/hmg/8.1.53.
10
(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.(CTG)n 重复介导的 DM1 成肌细胞中 MBNL1 和 MBNL2 表达的失调早在成肌细胞阶段就已经发生。
PLoS One. 2019 May 22;14(5):e0217317. doi: 10.1371/journal.pone.0217317. eCollection 2019.

引用本文的文献

1
Muscular Dystrophies.肌肉萎缩症
Adv Exp Med Biol. 2025;1478:245-284. doi: 10.1007/978-3-031-88361-3_11.
2
Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy.启动子靶向小RNA双链体增加MBNL1转录并减轻强直性肌营养不良相关的剪接异常。
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf756.
3
Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.永生化的1型强直性肌营养不良症人类肌肉细胞系,用于解决患者异质性问题。

本文引用的文献

1
Dynamic Cooperative Glycan Assembly Blocks the Binding of Bacterial Lectins to Epithelial Cells.动态协同糖基组装阻止细菌凝集素与上皮细胞的结合。
Angew Chem Int Ed Engl. 2017 Jun 6;56(24):6762-6766. doi: 10.1002/anie.201700813. Epub 2017 May 15.
2
Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.通过个性化的等位基因特异性CRISPR/Cas9实现亨廷顿舞蹈症突变的永久失活。
Hum Mol Genet. 2016 Oct 15;25(20):4566-4576. doi: 10.1093/hmg/ddw286.
3
Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
iScience. 2024 May 7;27(6):109930. doi: 10.1016/j.isci.2024.109930. eCollection 2024 Jun 21.
4
Promising AAV.U7snRNAs vectors targeting improve DM1 hallmarks in patient-derived cell lines.靶向改善患者来源细胞系中DM1特征的有前景的AAV.U7snRNAs载体。
Front Cell Dev Biol. 2023 Jun 15;11:1181040. doi: 10.3389/fcell.2023.1181040. eCollection 2023.
5
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1.1 型肌强直性营养不良反义疗法的研究进展与挑战
Int J Mol Sci. 2022 Nov 1;23(21):13359. doi: 10.3390/ijms232113359.
6
Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy.选择性和可逆性配体组装在肌强直性营养不良的 DNA 和 RNA 重复序列上。
Chembiochem. 2022 Sep 5;23(17):e202200260. doi: 10.1002/cbic.202200260. Epub 2022 Jul 19.
7
Perspectives on conformationally constrained peptide nucleic acid (PNA): insights into the structural design, properties and applications.构象受限肽核酸(PNA)的展望:对结构设计、性质及应用的见解
RSC Chem Biol. 2022 Mar 18;3(6):648-697. doi: 10.1039/d2cb00017b. eCollection 2022 Jun 8.
8
Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing.肌强直性营养不良 1 型的分子治疗:从小分子药物到基因编辑。
Int J Mol Sci. 2022 Apr 21;23(9):4622. doi: 10.3390/ijms23094622.
9
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1.1型强直性肌营养不良症的脑发病机制及潜在治疗策略
Front Aging Neurosci. 2021 Nov 15;13:755392. doi: 10.3389/fnagi.2021.755392. eCollection 2021.
10
Myotonic dystrophy type 1 drug development: A pipeline toward the market.1 型肌强直性营养不良药物研发:走向市场的管线。
Drug Discov Today. 2021 Jul;26(7):1765-1772. doi: 10.1016/j.drudis.2021.03.024. Epub 2021 Mar 31.
对有毒的CUG RNA重复扩增进行精确的小分子识别。
Nat Chem Biol. 2017 Feb;13(2):188-193. doi: 10.1038/nchembio.2251. Epub 2016 Dec 12.
4
Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.针对导致 1 型肌强直性营养不良的 DNA 和 RNA 的合理设计的小分子。
J Am Chem Soc. 2015 Nov 11;137(44):14180-9. doi: 10.1021/jacs.5b09266. Epub 2015 Nov 3.
5
Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.研究一个类药物的、以RNA为靶点的小分子文库,发现了可抑制强直性肌营养不良中RNA毒性的化合物。
ACS Chem Biol. 2015 Dec 18;10(12):2706-15. doi: 10.1021/acschembio.5b00430. Epub 2015 Sep 28.
6
Daily consumption of a mangosteen-based drink improves in vivo antioxidant and anti-inflammatory biomarkers in healthy adults: a randomized, double-blind, placebo-controlled clinical trial.每日饮用山竹果饮料可改善健康成年人的体内抗氧化和抗炎生物标志物:一项随机、双盲、安慰剂对照的临床试验。
Food Sci Nutr. 2015 Jul;3(4):342-8. doi: 10.1002/fsn3.225. Epub 2015 Apr 13.
7
Gamma Peptide Nucleic Acids: As Orthogonal Nucleic Acid Recognition Codes for Organizing Molecular Self-Assembly.伽马肽核酸:作为组织分子自组装的正交核酸识别码。
J Am Chem Soc. 2015 Jul 8;137(26):8603-10. doi: 10.1021/jacs.5b04566. Epub 2015 Jun 29.
8
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.短反义锁核酸(全锁核酸)可纠正强直性肌营养不良中的异常剪接。
Nucleic Acids Res. 2015 Mar 31;43(6):3318-31. doi: 10.1093/nar/gkv163. Epub 2015 Mar 9.
9
Peptide therapeutics: current status and future directions.肽类治疗药物:现状与未来方向。
Drug Discov Today. 2015 Jan;20(1):122-8. doi: 10.1016/j.drudis.2014.10.003. Epub 2014 Oct 17.
10
Highly specific contractions of a single CAG/CTG trinucleotide repeat by TALEN in yeast.在酵母中通过转录激活样效应因子核酸酶(TALEN)对单个CAG/CTG三核苷酸重复序列进行高度特异性收缩。
PLoS One. 2014 Apr 18;9(4):e95611. doi: 10.1371/journal.pone.0095611. eCollection 2014.